A stand-alone sequencing approach was accurate, cost effective and efficient for analyzing resistant pathogens and ...

After China placed Illumina on a government watchlist this week, in response to new tariffs imposed by the Trump ...

On Monday, for the second time in as many business days, Illumina (NASDAQ: ILMN) stock took it on the chin because of an ...

China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

Genomic sequencing specialist Illumina (NASDAQ: ILMN) was something of a victim in the U.S.-China trade spat on Tuesday.

China’s Ministry of Commerce on Tuesday added Illumina, a maker of DNA sequencing systems, to its unreliable entity list as ...

The company forecast annual revenue of $4.28 billion to $4.4 billion for 2025, the midpoint of which is below analysts' ...

For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...

Citi analyst Patrick Donnelly lowered the firm’s price target on Illumina (ILMN) to $130 from $165 and keeps a Neutral rating on the shares ...

The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $366,099, and 4 are calls, amounting to ...